You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TBPH Disposition Disclosure
Gray Susannah · SEC Form 4 · Filed Sep 24, 2026
Disposition
Reported value range
Not reported
Gray Susannah Director
TBPH
Theravance Biopharma
TBPH
Transaction date
Sep 23, 2026
Public filing date
Sep 24, 2026
Filing lag
Filed 1 day later
TBPH daily price context
Close on/before transaction
$17.03
Sep 23, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Share Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 24,258 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001833453-26-000009
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH | Disposition | Sep 23, 2026 | Not reported |
| Theravance Biopharma, Inc. TBPH Current | Disposition | Sep 23, 2026 | Not reported |